Founded in 2004, Saladax Biomedical, Inc. is a privately held company headquartered as an anchor tenant at Ben Franklin TechVentures® located in Bethlehem, PA. Saladax develops rapid blood tests to increase the impact of personalized medicine by bringing adherence testing to psychiatrists and chemotherapeutic drug monitoring to oncologists. Additionally, the company collaborates with leading pharmaceutical companies to develop tests for clinical trials and companion diagnostics. Saladax believes that truly personalized medicine can only exist when the right drug is taken at the right dose. Go to MyCareTests.com to view Saladax’s MyCare Psychiatry and MyCare Oncology lines of reagents.
Noteworthy Press Releases
- Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market
- Saladax is awarded “Best Poster Presentation” for study on individualized dosing of Paclitaxel
- Saladax Licenses Alzheimer’s Diagnostic Tests to Siemens Healthineers
- Biotech company founder Sal Salamone honored as one of New Jersey’s top inventors